DIABETES MEDICATION LINKED TO REDUCED RISK OF ALZHEIMER’S
A large study from Germany suggests that a readily available medication, Actos (Pioglitazone) may prevent Alzheimer’s disease from developing in diabetic patients, reducing their risk by 50%. This study, looked at the records over 150,000 patients and the connection between taking Actos long term, and reduced Alzheimer’s risk, was substantial…about 50%. This medication had been …
Read More “DIABETES MEDICATION LINKED TO REDUCED RISK OF ALZHEIMER’S”